期刊文献+

辛伐他汀片降解途径探究和处方工艺优化 被引量:1

Degradation Pathway and Prescription Process Optimization of Simvastatin Tablets
下载PDF
导出
摘要 通过处方筛选和工艺优化,解决辛伐他汀不稳定,极易发生降解等问题。从辛伐他汀的降解途径入手,根据辅料相容性试验、正交试验设计确定辅料用量;同时,对不同制粒工艺的进行比较考察。变更了处方工艺,新处方中添加了维生素C,调整各个辅料的用量,并由干法制粒改为湿法制粒工艺。试验结果表明,辛伐他汀片新处方合理,各项指标无显著变化,新处方工艺适用于大生产。 The instability and prone to degradation of simvastatin were resolved through formulation and process optimization.The orthogonal experiment of accessories compatibility test was designed to determine the amount of accessories.At the same time,different granulation processes were conducted comparatively.The prescription process was changed by addition of vitamin C and the amount of various accessories,simultaneously,and dry granulation was instead of wet granulation process.Results showed that a reasonable prescription of Simvastatin Tablets was established,and it was suitable for large-scale production for there were no significant changes in the various indicators.
出处 《广州化工》 CAS 2013年第2期58-61,共4页 GuangZhou Chemical Industry
关键词 辛伐他汀片 降解途径 处方筛选 工艺优化 Simvastatin Tablets degradation pathway formulation optimization process optimization
  • 相关文献

参考文献6

二级参考文献16

  • 1刘治安,汤远亮,李红玲,莫炫永,姚国新.不同厂家辛伐他汀口服制剂溶出度比较[J].中国药业,2006,15(20):12-13. 被引量:4
  • 2中国药典委员会.中华人民共和国药典(2005年版)[M].北京:中国医药科技出版社,2005.
  • 3Cleeman JI. Executive summary of the third repot of the national cholesterol education program (NCEP)expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JA MA,2001,285:2486.
  • 4Chong PH, Seeger JD, Franldin C. Clinically relevent differences between the statins: implications for therapeutic selection[J ]. Am J Med,2001, 111:390.
  • 5Maron DJ, Fazio S, Linton MF. Current perspectives on stafins[J ]. Circulation,2000,101:207.
  • 6Plenge JK, Hemandez TL, Well KM, et al. Simvastatin lowers creactive protein within 14 days An effect independent of lowdensity lipoprotein cholestero reduction[J ]. Circulation, 2002,106:1447.
  • 7Scandinavian Simvastatin Survival Study Group. Randomised trial of cholestrol lowering in 4 444 patients with coronary heart disease: the scandiwavian simvastatin survival stuay ( 4 s) [ J ].Lancet, 1994,344:1383.
  • 8Heart Protection Study Collborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals;a randomised plaeebo-controlled trial[J]. Lancet ,2002,306:7.
  • 9Pedersen TR, Berg K, Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 year in the scandinavian simvastatin survival study[J ]. Arch Intern Med, 1996,156:2085.
  • 10Pedersen TR, Willmlmsen L, Faergeman O, et al. Follow-up study of patientis randomized in the scandinavian simvastatin survival study (4 s) of cholesterol lowerlng[J]. Am J Cardiol,2000,86:257.

共引文献28

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部